Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012

Perk, 2012, European guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092 Ferket, 2010, Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?, Arch Intern Med, 170, 27, 10.1001/archinternmed.2009.434 Kotseva, 2009, EUROASPIREIII: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil, 16, 121, 10.1097/HJR.0b013e3283294b1d Brotons, 2004, Adaptación española de la guía europea de prevención cardiovascular, Rev Esp Salud Pública, 78, 435, 10.1590/S1135-57272004000400002 Lobos, 2008, Guía europea de prevención cardiovascular en la práctica clínica. Adaptación española del CEIPC 2008, Rev Esp Salud Pública, 82, 581, 10.1590/S1135-57272008000600002 Brotons, 2013, Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care, BMC Family Practice, 14, 36, 10.1186/1471-2296-14-36 Guyatt, 2008, GRADE: An emerging consensus on rating quality of evidence strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Grol, 1998, Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study, BMJ, 317, 858, 10.1136/bmj.317.7162.858 O’Kelly, 2009, The political power of heart doctors: With the European Heart Health Charter towards a European policy on cardiovascular disease, Eur J Cardiovasc Prev Rehabil, 16, S58, 10.1097/01.hjr.0000359239.52185.6a Villar F, Banegas JR, de Mata Donado J, Rodríguez Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2007. Sociedad Española de Arterioesclerosis. [Consultado 1 Sep 2012]. Disponible en: http://www.searteriosclerosis.org/resources/archivosbd/clinica_investigacion/4d34a5f3ab9cb226e076bb3b11abf587.pdf Flores-Mateo, 2011, Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005, Rev Esp Cardiol, 64, 988, 10.1016/j.recesp.2011.05.033 Guallar-Castillón, 2012, Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA study, Rev Esp Cardiol, 65, 551, 10.1016/j.recesp.2012.02.005 Banegas, 2012, Achievement of cardiometabolic goals in aware hypertensive patients in Spain. A nationwide population-based study, Hypertension, 60, 898, 10.1161/HYPERTENSIONAHA.112.193078 Grau, 2011, Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS, Rev Esp Cardiol, 64, 295, 10.1016/j.recesp.2010.11.005 Painter, 2006, Early onset of coronary artery disease after prenatal exposure to the Dutch famine, Am J Clin Nutr, 84, 322, 10.1093/ajcn/84.2.322 Birch, 1998, Development of eating behaviors among children and adolescents, Pediatrics, 101, 539, 10.1542/peds.101.S2.539 Dunn, 2000, Seven-year tracking of dietary factors in young adults: The CARDIA study, Am J Prev Med, 18, 38, 10.1016/S0749-3797(99)00114-2 Vos, 2003, Adolescent blood pressure and blood pressure tracking into young adulthood are related to subclinical atherosclerosis: The Atherosclerosis Risk in Young Adults (ARYA) study, Am J Hypertens, 16, 549, 10.1016/S0895-7061(03)00857-4 Agüero, 2013, Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: The REGICOR Study, PLoS One, 8, e53722, 10.1371/journal.pone.0053722 National Institute for Health and Clinical Excellence. Prevention of Cardiovascular Disease: Costing Report. 2010. Nice Public Health Guidance 25. [Consultado 10 Sep 2012]. Disponible en: http://www.nice.org.uk/nicemedia/live/13024/49325/49325.pdf Wood, 2008, Lancet, 371, 1999, 10.1016/S0140-6736(08)60868-5 Sans, 2007, Calibración de la tabla SCORE de riesgo cardiovascular para España, Rev Esp Cardiol, 60, 476, 10.1016/S0300-8932(07)75064-9 Royo-Bordonada, 2013, El estado de la prevención cardiovascular en España, Med Clin (Barc), 10.1016/j.medcli.2012.09.046 Marrugat, 2007, Validity of an adaptation of the Framingham cardiovascular risk function: The VERIFICA Study, J Epidemiol Community Health, 61, 40, 10.1136/jech.2005.038505 D’Agostino, 2008, General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 Cuende, 2010, How to calculate vascular age with the SCORE project scales: A new method of cardiovascular risk evaluation, Eur Heart J, 31, 2351, 10.1093/eurheartj/ehq205 Brugts, 2009, The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials, BMJ, 338, b2376, 10.1136/bmj.b2376 Rose, 1985, Sick individuals and sick populations, Int J Epidemiol, 14, 32, 10.1093/ije/14.1.32 Marrugat, 2011, Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR, Rev Esp Cardiol, 64, 385, 10.1016/j.recesp.2010.12.011 Hlatky, 2009, Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association, Circulation, 119, 2408, 10.1161/CIRCULATIONAHA.109.192278 Redondo, 2011, Trends in the prevalence, awareness, treatment, and control of cardiovascular risk factors across educational level in the 1995-2005 period, Ann Epidemiol, 21, 555, 10.1016/j.annepidem.2011.02.008 Nichol, 2003, Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly, N Engl J Med, 348, 1322, 10.1056/NEJMoa025028 Rubak, 2005, Motivational interviewing: A systematic review and meta-analysis, Br J Gen Pract, 55, 305 Rollnick, 2010, Motivational interviewing, BMJ, 340, c1900, 10.1136/bmj.c1900 Raupach, 2006, Secondhand smoke as an acute threat for the cardiovascular system: A change in paradigm, Eur Heart J, 27, 386, 10.1093/eurheartj/ehi601 Stead, 2008, Physician advice for smoking cessation, Cochrane Database Syst Rev, 2, CD000165 Lancaster, 2004, Physician advice for smoking cessation, Cochrane Database Syst Rev, 4, CD000165 Stead, 2008, Nicotine replacement therapy for smoking cessation, Cochrane Database Syst Rev, 1, CD000146 Stender, 2006, High levels of industrially produced trans fat in popular fast foods, N Engl J Med, 354, 1650, 10.1056/NEJMc052959 Huffman, 2012, Association or causation of sugar-sweetened beverages and coronary heart disease: Recalling Sir Austin Bradford Hill, Circulation, 125, 1718, 10.1161/CIRCULATIONAHA.112.097634 Estruch, 2013, Primary prevention of cardiovascular disease with a Mediterranean diet, N Engl J Med, 368, 1279, 10.1056/NEJMoa1200303 Sassi F, Cecchini M, Lauer J, Chisholm D. Improving Lifestyles, Tackling Obesity: The health and economic impact of prevention strategies. OECD Health Working Papers, No. 48. OECD Publishing. Paris: 2009 [consultado 12 Feb 2013] Disponible en: http://dx.doi.org/10.1787/220087432153 Nocon, 2008, Association of physical activity with all-cause and cardiovascular mortality: A systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil, 15, 239, 10.1097/HJR.0b013e3282f55e09 Haskell, 2007, Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association Circulation, 116, 1081 Heran, 2011, Exercise-based cardiac rehabilitation for coronary heart disease, Cochrane Database Syst Rev, 7, CD001800 Wisløff, 2007, Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study, Circulation, 115, 3086, 10.1161/CIRCULATIONAHA.106.675041 Ziegelstein, 2009, Routine screening for depression in patients with coronary heart disease: Never mind, J Am Coll Cardiol, 54, 886, 10.1016/j.jacc.2009.01.082 Whalley, 2011, Psychological interventions for coronary heart disease, Cochrane Database Syst Rev, 8, CD002902 Gulliksson, 2011, Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM), Arch Intern Med, 171, 134, 10.1001/archinternmed.2010.510 Taylor, 2010, Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: A study using data from 4 UK cohorts, Am J Clin Nutr, 91, 547, 10.3945/ajcn.2009.28757 Gutiérrez-Fisac, 2006, Riesgos asociados a la dieta occidental y al sedentarismo: La epidemia de obesidad. Informe SESPAS 2006, Gac Sanit, 20, 48, 10.1157/13086026 Volpe, 2012, Cardiovascular risk assessment beyond systemic coronary risk estimation: A role for organ damage markers, J Hypertens, 30, 1056, 10.1097/HJH.0b013e3283525715 Beckett, 2008, Treatment of hypertension in patients 80 years of age or older, N Engl J Med, 358, 1887, 10.1056/NEJMoa0801369 Cano, 2010, Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: A population-based cohort study in southern Europe, Diabetes Care, 33, 2004, 10.2337/dc10-0560 2012, Position Statement: Standards of medical care in diabetes-2012, Diabetes Care, 35, S11 Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158 Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Engl J Med, 357, 2109, 10.1056/NEJMoa0706628 Fuentes, 2012, Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style, Neurología, 27, 560, 10.1016/j.nrl.2011.06.002 Lackland, 2012, Inclusion of stroke in cardiovascular risk prediction instruments: A statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 43, 1998, 10.1161/STR.0b013e31825bcdac McKinney, 2012, Statin therapy and the risk of intracerebral hemorrhage: A meta-analysis of 31 randomized controlled trials, Stroke, 43, 2149, 10.1161/STROKEAHA.112.655894 Baigent, 2009, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 O’Gara, 2013, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019 Park, 2010, Duration of dual antiplatelet therapy after implantation of drug-eluting stents, N Engl J Med, 362, 1374, 10.1056/NEJMoa1001266 Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989 Diener, 2004, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial, Lancet, 364, 331, 10.1016/S0140-6736(04)16721-4 Doshi, 2009, Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans, Circulation, 119, 390, 10.1161/CIRCULATIONAHA.108.783944 Berra, 2011, Global cardiovascular disease prevention: A call to action for nursing: the global burden of cardiovascular disease, J Cardiovasc Nurs, 26, S1, 10.1097/JCN.0b013e31821485da Kotseva, 2010, EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: Cross-sectional survey in 12 European countries, Eur J Cardiovasc Prev Rehabil, 17, 530, 10.1097/HJR.0b013e3283383f30 Elustondo, 2013, Cardiovascular risk tables: Opinion and degree of use of Primary Care doctors from Madrid, Spain, J Eval Clin Pract, 19, 148, 10.1111/j.1365-2753.2011.01785.x Wells, 2008, Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice, Eur J Cardiovasc Prev Rehabil, 15, 173, 10.1097/HJR.0b013e3282f13af4 Bramlage, 2010, The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction, Heart, 96, 604, 10.1136/hrt.2009.188607 Jolliffe, 2011, Exercise based rehabilitation for coronary heart disease, Cochrane Database Syst Rev, 7, CD001800 Giannuzzi, 2008, Global secondary prevention strategies to limit event recurrence after myocardial infarction: Results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network, Arch Intern Med, 168, 2194, 10.1001/archinte.168.20.2194 Bjarnason-Wehrens, 2010, Cardiac Rehabilitation Section European Association of Cardiovascular Prevention and Rehabilitation. Cardiac rehabilitation in Europe: Results from the European Cardiac Rehabilitation Inventory Survey (ECRIS), Eur J Cardiovasc Prev Rehabil, 17, 410, 10.1097/HJR.0b013e328334f42d